227 related articles for article (PubMed ID: 21631655)
1. The human metapneumovirus: a case series and review of the literature.
Shahda S; Carlos WG; Kiel PJ; Khan BA; Hage CA
Transpl Infect Dis; 2011 Jun; 13(3):324-8. PubMed ID: 21631655
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
[TBL] [Abstract][Full Text] [Related]
3. Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation.
Egli A; Bucher C; Dumoulin A; Stern M; Buser A; Bubendorf L; Gregor M; Servida P; Sommer G; Bremerich J; Gratwohl A; Khanna N; Widmer AF; Battegay M; Tamm M; Hirsch HH; Halter JP
Infection; 2012 Dec; 40(6):677-84. PubMed ID: 22802096
[TBL] [Abstract][Full Text] [Related]
4. Treatment with oral ribavirin and IVIG of severe human metapneumovirus pneumonia (HMPV) in immune compromised child.
Shachor-Meyouhas Y; Ben-Barak A; Kassis I
Pediatr Blood Cancer; 2011 Aug; 57(2):350-1. PubMed ID: 21671370
[No Abstract] [Full Text] [Related]
5. Treatment of severe human metapneumovirus (hMPV) pneumonia in an immunocompromised child with oral ribavirin and IVIG.
Kitanovski L; Kopriva S; Pokorn M; Dolničar MB; Rajić V; Stefanović M; Jazbec J
J Pediatr Hematol Oncol; 2013 Oct; 35(7):e311-3. PubMed ID: 23669731
[TBL] [Abstract][Full Text] [Related]
6. Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review.
Shah DP; Shah PK; Azzi JM; El Chaer F; Chemaly RF
Cancer Lett; 2016 Aug; 379(1):100-6. PubMed ID: 27260872
[TBL] [Abstract][Full Text] [Related]
7. Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin.
Raza K; Ismailjee SB; Crespo M; Studer SM; Sanghavi S; Paterson DL; Kwak EJ; Rinaldo CR; Pilewski JM; McCurry KR; Husain S
J Heart Lung Transplant; 2007 Aug; 26(8):862-4. PubMed ID: 17692793
[TBL] [Abstract][Full Text] [Related]
8. Human metapneumovirus in haematopoietic stem cell transplantation recipients: a case series and review of the diagnostic and therapeutic approach.
Hoppe BP; de Jongh E; Griffioen-Keijzer A; Zijlstra-Baalbergen JM; IJzerman EP; Baboe F
Neth J Med; 2016 Oct; 74(8):336-341. PubMed ID: 27762221
[TBL] [Abstract][Full Text] [Related]
9. Human metapneumovirus (hMPV) infection in immunocompromised children.
Scheuerman O; Barkai G; Mandelboim M; Mishali H; Chodick G; Levy I
J Clin Virol; 2016 Oct; 83():12-6. PubMed ID: 27522636
[TBL] [Abstract][Full Text] [Related]
10. Human metapneumovirus in lung transplant recipients: characteristics and outcomes.
Niggli F; Huber LC; Benden C; Schuurmans MM
Infect Dis (Lond); 2016; 48(11-12):852-6. PubMed ID: 27385394
[TBL] [Abstract][Full Text] [Related]
11. Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients.
Renaud C; Xie H; Seo S; Kuypers J; Cent A; Corey L; Leisenring W; Boeckh M; Englund JA
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1220-6. PubMed ID: 23680472
[TBL] [Abstract][Full Text] [Related]
12. Fatal human metapneumovirus infection following allogeneic hematopoietic stem cell transplantation.
Dokos C; Masjosthusmann K; Rellensmann G; Werner C; Schuler-Lüttmann S; Müller KM; Schiborr M; Ehlert K; Groll AH
Transpl Infect Dis; 2013 Jun; 15(3):E97-E101. PubMed ID: 23551689
[TBL] [Abstract][Full Text] [Related]
13. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients.
Englund JA; Boeckh M; Kuypers J; Nichols WG; Hackman RC; Morrow RA; Fredricks DN; Corey L
Ann Intern Med; 2006 Mar; 144(5):344-9. PubMed ID: 16520475
[TBL] [Abstract][Full Text] [Related]
14. Serious outbreak of human metapneumovirus in patients with hematologic malignancies.
Hoellein A; Hecker J; Hoffmann D; Göttle F; Protzer U; Peschel C; Götze K
Leuk Lymphoma; 2016; 57(3):623-7. PubMed ID: 26122193
[TBL] [Abstract][Full Text] [Related]
15. Immune modulatory activity of ribavirin for serious human metapneumovirus disease: early i.v. therapy may improve outcomes in immunosuppressed SCT recipients.
Safdar A
Bone Marrow Transplant; 2008 Apr; 41(8):707-8. PubMed ID: 18347567
[No Abstract] [Full Text] [Related]
16. Human metapneumovirus.
Kroll JL; Weinberg A
Semin Respir Crit Care Med; 2011 Aug; 32(4):447-53. PubMed ID: 21858749
[TBL] [Abstract][Full Text] [Related]
17. Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation.
Balassa K; Salisbury R; Watson E; Lubowiecki M; Tseu B; Maouche N; Jeffery K; Misbah SA; Benamore R; Rowley L; Barton D; Pawson R; Danby R; Rocha V; Peniket A
J Infect; 2019 Jun; 78(6):461-467. PubMed ID: 30965067
[TBL] [Abstract][Full Text] [Related]
18. Metapneumovirus Infections and Respiratory Complications.
Esposito S; Mastrolia MV
Semin Respir Crit Care Med; 2016 Aug; 37(4):512-21. PubMed ID: 27486733
[TBL] [Abstract][Full Text] [Related]
19. [Human metapneumovirus--occurrence and clinical significance].
Risnes KR; Radtke A; Nordbø SA; Grammeltvedt AT; Døllner H
Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2769-72. PubMed ID: 16244677
[TBL] [Abstract][Full Text] [Related]
20. Antiviral therapy for respiratory viral infections in immunocompromised patients.
Shahani L; Ariza-Heredia EJ; Chemaly RF
Expert Rev Anti Infect Ther; 2017 Apr; 15(4):401-415. PubMed ID: 28067078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
